Siemens introduces "Generation NeXt" - A New Class of Ultrasound Systems

SIEMENSUnder the banner "Generation NeXt", Siemens Medical Solutions demonstrates excellence in systems design and applications software for increased flexibility in cardiology and shared service at EUROECHO 10 in Prague, Czechia. The ultrasound systems Acuson X300 and Acuson Antares, both shown for the first time at a cardiology congress, provide outstanding performance through advanced offline and online applications such as the syngo Arterial Health Package and syngo Mitral Valve Assessment.

SIEMENS Generation NeXtThe Acuson X300, the latest member of the new Siemens X Class of Ultrasound systems, is an ultra-compact, performance-oriented system and uniquely positioned to become the go-to system in busy settings such as emergency rooms. With an operatorfriendly console that helps to reduce arm and hand movement, and its small, lightweight transducers, the X300 takes the pain and pressure out of routine scanning. A flat panel display, height adjustable control panel and its light weight design enables a comfortable scanning position for the user, even in tight exam spaces such as the patient's bedside. The system's TGO (tissue grayscale optimization) technology delivers consistent image quality, while advanced Hanafy lens transducers enable improved image uniformity when scanning technically difficult-to-image patients.

With the introduction of shared service capabilities to the Acuson Antares ultrasound system, the benefits of a revolutionary design as well as the outstanding image quality and versatility will now also be available to the cardiologist. The Antares system, premium edition, 5.0 release is equipped with a high-resolution 19-inch flat panel display mounted on an articulating arm for optimal viewing position. Other ergonomic design features include the natural and extended reach zone concept that places controls and peripheral devices so they are easily accessible allowing for more comfortable patient exams, and improved examination and departmental workflow.

In addition to the two "Generation NeXt" ultrasound systems, Siemens also brings two new applications to its offline software platform, syngo Ultrasound Workplace. "Making advanced applications available offline the ultrasound system is essential in today's busy healthcare environment," said Klaus Hambuechen, President of Siemens' Ultrasound. "By freeing the ultrasound unit from postprocessing and other measurement procedures, healthcare providers will improve their workflow while at the same time increase the quality of care for their patients." The syngo Arterial Health Package allows the evaluation of cardiac risk factors and quantification of cardiovascular age with automated intima-media thickness measurements while the syngo Mitral Valve Assessment application provides for a rapid 3D/4D evaluation of mitral valve morphology and pathology for diagnosis and planning of surgical procedures. Both of these applications will also be available "online" on the Acuson Sequoia ultrasound system's 12.0 release.

Siemens Medical Solutions is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. From imaging systems for diagnosis, to therapy equipment for treatment, to molecular medicine to hearing instruments and beyond, Siemens innovations contribute to the health and well-being of people across the globe, while improving operational efficiencies and optimizing workflow in hospitals, clinics, home health agencies, and doctors' offices. Recent acquisitions in the area of in-vitro diagnostics – such as Diagnostic Products Corporation – mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing approximately 36,000 people worldwide and operating in more than 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1,06 billion EUR for fiscal 2006 (preliminary figures). Further information can be found under: http://www.siemens.com/medical

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...